- Home
- MDXG vs BHVN Comparison
MDXG vs BHVN Comparison
Compare MDXG & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BHVN
- Stock Information
- Founded
- MDXG 2006
- BHVN 2013
- Country
- MDXG United States
- BHVN United States
- Employees
- MDXG N/A
- BHVN N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- MDXG Health Care
- BHVN Health Care
- Exchange
- MDXG Nasdaq
- BHVN Nasdaq
- Market Cap
- MDXG 1.0B
- BHVN 1.1B
- IPO Year
- MDXG N/A
- BHVN 2017
- Fundamental
- Price
- MDXG $7.12
- BHVN $8.15
- Analyst Decision
- MDXG Buy
- BHVN Strong Buy
- Analyst Count
- MDXG 1
- BHVN 16
- Target Price
- MDXG $12.00
- BHVN $37.07
- AVG Volume (30 Days)
- MDXG 1.2M
- BHVN 5.6M
- Earning Date
- MDXG 10-29-2025
- BHVN 11-10-2025
- Dividend Yield
- MDXG N/A
- BHVN N/A
- EPS Growth
- MDXG N/A
- BHVN N/A
- EPS
- MDXG 0.27
- BHVN N/A
- Revenue
- MDXG $393,442,000.00
- BHVN N/A
- Revenue This Year
- MDXG $19.01
- BHVN N/A
- Revenue Next Year
- MDXG $2.36
- BHVN $2,079.03
- P/E Ratio
- MDXG $26.29
- BHVN N/A
- Revenue Growth
- MDXG 14.77
- BHVN N/A
- 52 Week Low
- MDXG $5.79
- BHVN $7.48
- 52 Week High
- MDXG $10.14
- BHVN $47.75
- Technical
- Relative Strength Index (RSI)
- MDXG 46.92
- BHVN 29.25
- Support Level
- MDXG $7.23
- BHVN $7.48
- Resistance Level
- MDXG $7.63
- BHVN $8.77
- Average True Range (ATR)
- MDXG 0.41
- BHVN 1.12
- MACD
- MDXG -0.03
- BHVN -0.57
- Stochastic Oscillator
- MDXG 29.68
- BHVN 6.59
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.